-
Development of a consensus-based delineation guideline for locally recurrent rectal cancer
Piqeur, F., Hupkens, B. J. P., Nordkamp, S., Witte, M. G., Meijnen, P., Ceha, H. M., Berbee, M., Dieters, M., Heyman, S., Valdman, A., Nilsson, M. P., Nederend, J., Rutten, H. J. T., Burger, J. W. A., Marijnen, C. A. M. & Peulen, H. M. U., 1 Dec 2022, In: Radiotherapy and oncology. 177, p. 214-221 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., & 10 others , Dec 2022, In: BMC Cancer. 22, 1, p. 957 1 p., 957.Research output: Contribution to journal › Article › Academic › peer-review
-
Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: Study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)
PelvEx Collaborative, 1 May 2021, In: BJS Open. 5, 3, zrab029.Research output: Contribution to journal › Article › Academic › peer-review
- All publications